Literature DB >> 173738

Epidemiologic study of a leukocyte-transforming agent in a general population.

C V Sumaya.   

Abstract

Studies by others have demonstrated a leukocyte-transforming agent(s) (LTA) in the oropharyngeal secretions of a significant number of individuals with Epstein-Barr virus-associated infectious mononucleosis, cancer, and, to a lesser extent, an outpatient population. This present study determines by systematic sampling the prevalence of LTA in 27 families of a semirural community. Throat swab inoculums from three of 54 adults and none of 44 children induced transformation of umbilical cord lymphocytes. Complement-dependent Epstein-Barr virus nuclear antigen was detected in two of the three transformed cell cultures. The three LTA-positive individuals were characterized by the absence of serologic evidence of a recent Epstein-Barr virus infection and the lack of elevated antibodies against the viral capsid antigen of Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173738      PMCID: PMC275214          DOI: 10.1128/jcm.2.6.520-523.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Seroepidemiologic study of Epstein-Barr virus infections in a rural community.

Authors:  C V Sumaya; W Henle; G Henle; M H Smith; D LeBlanc
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

2.  Immune control of herpes simplex virus infections.

Authors:  F A Ennis; M Wells
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

3.  Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).

Authors:  F D Anderson; R N Ushijima; C L Larson
Journal:  Obstet Gynecol       Date:  1974-06       Impact factor: 7.661

4.  False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen.

Authors:  W Henle; A Guerra; G Henle
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

Review 5.  Infection with herpes-simplex viruses 1 and 2. II.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

6.  Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals.

Authors:  H D Golden; R S Chang; W Prescott; E Simpson; T Y Cooper
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

7.  Evidence for oral excretion of E.B. virus in infectious mononucleosis.

Authors:  M S Pereira; A M Field; J M Blake; F G Rodgers; L A Bailey; J R Davies
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

8.  Delayed hypersensitivity skin testing. II. Clinical correlates and anergy.

Authors:  D L Palmer; W P Reed
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

9.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.

Authors:  G Henle; W Henle; P Clifford; V Diehl; G W Kafuko; B G Kirya; G Klein; R H Morrow; G M Munube; P Pike; P M Tukei; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

10.  Transformation of human leucocytes by throat washing from infectious mononucleosis patients.

Authors:  R S Chang; H D Golden
Journal:  Nature       Date:  1971-12-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.